EARNEST Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-112
| Closed | -$13K | – | 1164 |
|
2023
Q3 | $13K | Hold |
112
| – | – | ﹤0.01% | 574 |
|
2023
Q2 | $11.5K | Hold |
112
| – | – | ﹤0.01% | 600 |
|
2023
Q1 | $12.2K | Hold |
112
| – | – | ﹤0.01% | 581 |
|
2022
Q4 | $12.7K | Hold |
112
| – | – | ﹤0.01% | 567 |
|
2022
Q3 | $7K | Hold |
112
| – | – | ﹤0.01% | 698 |
|
2022
Q2 | $9K | Hold |
112
| – | – | ﹤0.01% | 645 |
|
2022
Q1 | $12K | Hold |
112
| – | – | ﹤0.01% | 613 |
|
2021
Q4 | $12K | Hold |
112
| – | – | ﹤0.01% | 641 |
|
2021
Q3 | $12K | Hold |
112
| – | – | ﹤0.01% | 618 |
|
2021
Q2 | $10K | Hold |
112
| – | – | ﹤0.01% | 675 |
|
2021
Q1 | $10K | Hold |
112
| – | – | ﹤0.01% | 650 |
|
2020
Q4 | $8K | Hold |
112
| – | – | ﹤0.01% | 704 |
|
2020
Q3 | $9K | Buy |
+112
| New | +$9K | ﹤0.01% | 611 |
|